[Retracted] AKR1C1 alleviates LPSinduced ALI in mice by activating the JAK2/STAT3 signaling pathway

Xianjun Wang1, Baocheng Yang1, Yuyu Li1

  • 1Emergency Observation Ward, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222002, P.R. China.

PubMed

Insights

This paper has been retracted due to duplicated immunohistochemical data previously published in another journal. The authors agreed with the retraction decision.

Area of Science:

  • Biochemistry
  • Immunohistochemistry
  • Scientific Publishing Ethics

Context:

  • A study published in Molecular Medicine Reports featured immunohistochemical data.
  • Concerns were raised regarding the similarity of this data to previously published work.

Purpose:

  • To address allegations of data duplication in a published scientific paper.
  • To maintain the integrity of scientific literature.

Summary:

  • The Editor of Molecular Medicine Reports retracted a paper after a reader identified similar immunohistochemical data to a prior publication.
  • The data in question was from Fig. 1C.
  • The authors consented to the retraction.

Impact:

  • Retraction upholds scientific integrity and ethical publishing standards.
  • Ensures accurate representation of research findings in the scientific community.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K